Phase III trial of rosiptor in interstitial cystitis/bladder pain syndrome misses primary endpoint June 27, 2018
Aquinox initiates phase II study of rosiptor in chronic prostatitis/chronic pelvic pain syndrome June 12, 2018
Pfizer initiates phase II study of PF-06730512 in primary focal segmental glomerulosclerosis June 11, 2018
Bardoxolone methyl receives orphan drug designation in Europe for the treatment of Alport syndrome June 4, 2018
Kyowa Hakko Kirin initiated phase III trial of bardoxolone methyl for diabetic kidney disease June 4, 2018
RSS